It has recently been suggested that manipulation of FABP4 by using neutralizing antibodies, specific inhibitors or unidentified receptor blockers would be a novel therapeutic strategy for several cardiovascular and metabolic diseases (3). The gene discussed is FABP4; the disease is Other metabolic disease.